Choosing the right platform for a judo club's online presence is crucial for its growth and community engagement. While Facebook is a popular and versatile social network, Judo Connect offers specific advantages tailored to the needs and aspirations of judo clubs. Here are three main reasons why Judo Connect is a better choice for a judo club compared to using Facebook as their primary social network:

We are #aruproud of the ARU Peterborough #RaceforLife team for taking part in the Stamford Pretty Muddy 5k this month. It looks like they had an amazing time, raising over £300 for #CancerResearch in the process. Well done everyone.
#teamwork #charity #fundraising #PrettyMuddy

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

A new study led by Professor Chris Parris and Dr Hussein Al-Ali at ARU demonstrated the efficacy of MDX-124, a revolutionary medicine that targets annexin-A1, a protein associated to various cancer forms.

This innovative treatment drastically lowers cancer cell proliferation and tumour growth in vivo. The ongoing clinical trial ATTAINMENT seeks to further assess MDX-124's safety and efficacy in cancer treatment.

Find out more here: https://ow.ly/yMe850QsZin
#CancerResearch #MDX124 #Immunotherapy #ARUInnovates

🎙️ New Episode Drop! 🎙️ Explore the cutting-edge world of AI in cancer research with Professor Gustavo Carneiro in: Will AI cure cancer?" 🔬 Uncover the role of AI in early detection and its revolutionary impact. Tune in now:
Spotify: https://ow.ly/UoBJ50Qi5KG
Apple: https://ow.ly/kQaK50Qi5KJ

🎧 #AIinMedicine #CancerResearch #WillAIPodcast

This weekend Sharon, Trudi and Emma are doing an overnight walking marathon to raise money for cancer research.

Any sponsorship would be gratefully received !!!

https://fundraise.cancerre...

Donation page for Emma, Sharon, Trudi and Julie. 1 in 2 people will be diagnosed with cancer in their lifetime. Every single pound you donate makes a difference to Cancer Research UK’s ground breaking work. Donate to my Giving Page today and help bring forward the day when all cancers are cur

🎙️ New Episode Drop! 🎙️ Explore the cutting-edge world of AI in cancer research with Professor Gustavo Carneiro in: Will AI cure cancer?" 🔬 Uncover the role of AI in early detection and its revolutionary impact. Tune in now:
Spotify: https://ow.ly/UoBJ50Qi5KG
Apple: https://ow.ly/kQaK50Qi5KJ

🎧 #AIinMedicine #CancerResearch #WillAIPodcast

This weekend Sharon, Trudi and Emma are doing an overnight walking marathon to raise money for cancer research.

Any sponsorship would be gratefully received !!!

https://fundraise.cancerre...

Donation page for Emma, Sharon, Trudi and Julie. 1 in 2 people will be diagnosed with cancer in their lifetime. Every single pound you donate makes a difference to Cancer Research UK’s ground breaking work. Donate to my Giving Page today and help bring forward the day when all cancers are cur